Floatz logo

FAPI74

Metastatic Invasive Lobular Breast Cancer

Randy YehSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Metastatic Invasive Lobular Breast Cancer cohort.

Asset / SponsorPhaseRating
FULVESTRANT
M.D. Anderson Cancer Center
Phase 3BB
Arimidex
Alliance for Clinical Trials in Oncology
Phase 3B
FES F-18
Asan Medical Center
Phase 2B
FLUDEOXYGLUCOSE
Randy Yeh
Phase 2CCC
Neratinib
Vanderbilt-Ingram Cancer Center
Phase 2CCC

View all 21 →

Same molecule, other indications

FAPI74 is also rated in:

digestive system cancerDormant
B
Indicative ·
57 / 100
View asset →
cholangiocarcinomaDormant
CCC
Indicative ·
54 / 100
View asset →
small cell lung carcinomaDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →